Legislators have mixed views on whether to classify fentanyl as a schedule I substance
Regulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy